Global Pancreas Malignant Neoplasms Mortality by Country

The analysis of global pancreas malignant neoplasms mortality in 2024, expressed in deaths per hundred thousand persons with standardized rates, shows Hungary having the highest mortality rate at 19.3. Most European countries like the Czech Republic, Finland, and Germany exhibit rates above 17, indicating a significant regional prevalence. The United States shows a rate of 14.1, similar to other countries like Bulgaria and Belgium. South American countries like Peru and Colombia have lower rates, with values of 7.7 and 7.5, respectively, reflecting less prevalence in these regions.

The year-on-year variations for 2023 indicate minor decreases in mortality in places like Hungary and Finland, while countries like Iceland and Peru have experienced more substantial increases in mortality rates. Notably, Bulgaria and Brazil show significant upward trends. The Compounded Annual Growth Rate (CAGR) over the last five years suggests slow annual changes, with slight increases or decreases in most countries.

Future trends to watch include advancements in early detection and treatment methods that could help reduce these mortality rates globally. Public health measures and lifestyle changes may affect the differences across regions. Additionally, global comparisons may shift due to the varying pace of medical advancements and health policy implementations. Monitoring these changes will be vital for understanding the global landscape of pancreatic cancer mortality.